Challenges With the Intolerance of Biologics in Severe Eosinophilic Asthma: The Risk of Exacerbations Is Time-Dependent With the Rise of Eosinophils
Abstract
Patients with severe eosinophilic asthma (SEA) can benefit from biologic therapy but some subjects may present an immune-mediated side effect. These patients will not meet the treatment goals and might have an increased risk of exacerbations. Monitoring these patients by determining blood eosinophil (BE) levels could be one of the tools that may allow a follow-up to prevent a worsening of asthma or exacerbations. The patient was a 50-year-old female with a diagnosis of SEA who had six asthma exacerbations in the last year. Baseline spirometry showed a forced expiratory volume in one second (FEV1) (L) of 0.80 with 34%p (z-score: -4.18) post bronchodilator (BD) and a BE count of 15% (1080 µL cells). After three doses of benralizumab, the spirometry showed an FEV1 (L) of 2.31 with 97%p (z-score: -0.21) post BD and a BE count of 0%. No exacerbations were reported while the patient received biologic medication, but it had to be stopped due to a dermatological allergic reaction. The patient was well-controlled for four months after stopping biologic medication and the BE count also increased, associated with two emergency visits due to exacerbations despite maintenance therapy. Although intolerance or hypersensitivity reactions to the treatment with biologics in asthmatic patients are rare, these patients must discontinue treatment, which increases their risk of exacerbations. In routine medical clinical practice, an easy approach can be made with the follow-up of an accessible…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects
- Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study
- Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
- Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.